BioLineRx (BLRX) EBITDA (2013 - 2025)
BioLineRx (BLRX) posted EBITDA of -$3.4 million for Q4 2025, down 246.57% on a QoQ basis from -$977000.0 in Q3 2025, and up 23.5% year-over-year from -$2.7 million in Q4 2024.
BioLineRx (BLRX) has 13 years of EBITDA data on file, last reported at -$3.4 million in Q4 2025.
- In Q4 2025, EBITDA rose 23.5% year-over-year to -$3.4 million; the TTM figure through Dec 2025 stood at -$3.2 million (up 69.64% YoY), while the FY2025 annual figure was -$10.3 million, up 49.59% from the prior year.
- EBITDA retreated to -$3.4 million in Q4 2025, from -$977000.0 in the prior quarter.
- Across five years, EBITDA topped out at $42.9 million in Q2 2023 and bottomed at -$39.8 million in Q3 2021.
- A 5-year average of -$3.6 million and a median of -$5.6 million in 2022 frame the typical range for EBITDA.
- The widest YoY moves for EBITDA: up 836.64% in 2025, down 533.92% in 2025.
- Year by year, EBITDA stood at -$6.6 million in 2021, then fell by 27.28% to -$8.4 million in 2022, then sank by 121.08% to -$18.6 million in 2023, then surged by 76.16% to -$4.4 million in 2024, then gained by 23.5% to -$3.4 million in 2025.
- The last three EBITDA figures came in at -$3.4 million (Q4 2025), -$977000.0 (Q3 2025), and -$3.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 201.19 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | -3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -977,000.00 |
| Jun 30, 2025 | -3.94 Mn |
| Mar 31, 2025 | 5.13 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -6.25 Mn |
| Jun 30, 2024 | 908,000.00 |
| Mar 31, 2024 | -696,000.00 |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.36 Mn |
| Jun 30, 2023 | 42.87 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -8.40 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -4.93 Mn |
| Dec 31, 2021 | -6.60 Mn |
| Sep 30, 2021 | -39.78 Mn |
| Jun 30, 2021 | 27.23 Mn |
| Mar 31, 2021 | -10.19 Mn |
| Dec 31, 2020 | -5.87 Mn |
| Sep 30, 2020 | -31.45 Mn |
| Jun 30, 2020 | 20.06 Mn |
| Mar 31, 2020 | -6.65 Mn |
| Dec 31, 2019 | -9.41 Mn |
| Sep 30, 2019 | -27.22 Mn |
| Jun 30, 2019 | 17.80 Mn |
| Mar 31, 2019 | -6.16 Mn |
| Dec 31, 2018 | -7.04 Mn |
| Sep 30, 2018 | -28.30 Mn |
| Jun 30, 2018 | 17.18 Mn |
| Mar 31, 2018 | -6.20 Mn |
| Dec 31, 2017 | -7.69 Mn |
| Sep 30, 2017 | -26.75 Mn |
| Jun 30, 2017 | 14.61 Mn |
| Mar 31, 2017 | -4.86 Mn |
| Dec 31, 2016 | -4.29 Mn |
| Sep 30, 2016 | -4.33 Mn |
| Jun 30, 2016 | -3.73 Mn |
| Mar 31, 2016 | -3.49 Mn |
| Dec 31, 2015 | -3.65 Mn |
| Sep 30, 2015 | -1.63 Mn |
| Jun 30, 2015 | -4.81 Mn |
| Mar 31, 2015 | -4.31 Mn |
| Dec 31, 2014 | -5.29 Mn |
| Sep 30, 2014 | -2.73 Mn |
| Jun 30, 2014 | -3.64 Mn |
| Mar 31, 2014 | -2.12 Mn |
| Dec 31, 2013 | -2.90 Mn |
| Sep 30, 2013 | -4.99 Mn |
| Jun 30, 2013 | -4.30 Mn |
| Mar 31, 2013 | -3.52 Mn |